Hospital payment schemes and high-priced drugs: Evidence from the French Add-on List.
Sign Up to like & getrecommendations! Published in 2021 at "Health policy"
DOI: 10.1016/j.healthpol.2021.04.012
Abstract: Under prospective payment schemes, hospitals may be disincentivised to use high-priced drugs. In this context, supplementary payment schemes have been implemented to fund hospitals beyond hospital tariffs for the use of such technologies. In France,… read more here.
Keywords: priced drugs; high priced; hospital; add list ... See more keywords
Changes in consumption patterns during the COVID-19 pandemic: Analyzing the revenge spending motivations of different emotional groups
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Retailing and Consumer Services"
DOI: 10.1016/j.jretconser.2021.102874
Abstract: People tend to alleviate their negative emotions by shopping. Considering the change of shopping behavior during COVID-19 outbreak, negative emotions are the key contributors to this change. In this light, this study aims to investigate… read more here.
Keywords: shopping; emotional groups; shopping intentions; negative emotions ... See more keywords
When Reality Does Not Meet Expectations—Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Environmental Research and Public Health"
DOI: 10.3390/ijerph20010340
Abstract: This study aimed to identify the current experiences with and future preferences for payment and reimbursement models for high-priced hospital therapies in the Netherlands, where the main barriers lie and assess how policy structures facilitate… read more here.
Keywords: payment reimbursement; reimbursement; reimbursement models; high priced ... See more keywords